ArticleProceedings of the National Academy of Sciences of the United States of America2025
Correction to Supporting Information for Jensen et al., Bcl2L13 is a ceramide synthase inhibitor in glioblastoma.
PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.